对细菌和真菌细胞因子反应改变的系统生物学评估揭示精神分裂症患者免疫功能受损
研究系统比较精神分裂症患者与对照外周血单核细胞对细菌、真菌及纯化微生物配体的细胞因子反应,发现患者存在异常反应模式及MDP刺激后细胞因子产生减少。单细胞RNA测序显示MDP刺激后多个免疫细胞亚群抗病毒与炎症程序广泛抑制、趋化因子/细胞因子-受体互作网络受损。患者血清MDP水平升高且与疾病病程相关。
要点
- 精神分裂症患者外周血单核细胞对多种病原体呈现异常细胞因子反应模式
- MDP刺激后患者多种免疫细胞亚群抗病毒与炎症程序广泛抑制
- 患者血清MDP水平升高并与疾病病程相关,提示细菌易位随疾病进展增加
核心结论
- 研究描绘了精神分裂症免疫功能受损的分子与细胞图景,提出先天免疫受损、病原体清除减少、MDP易位增加与先天免疫反应钝化之间存在相互作用的假说。
研究设计与样本
- 研究比较精神分裂症患者与对照的外周血单核细胞对细菌、真菌及纯化微生物配体的细胞因子反应。
- 对未刺激和刺激后的外周血单核细胞进行单细胞RNA测序。
- 进行体外实验检测MDP预处理对正常外周血单核细胞再刺激功能反应的影响。
主要发现
- 精神分裂症患者对多种病原体呈现异常细胞因子反应模式,MDP刺激后细胞因子产生减少。
- 单细胞RNA测序显示MDP刺激后患者多种免疫细胞亚群抗病毒与炎症程序广泛抑制,趋化因子/细胞因子-受体互作网络受损。
- 患者血清MDP水平升高,且与疾病病程相关。
- 体外实验显示MDP预处理改变正常外周血单核细胞对再刺激的功能反应,部分再现精神分裂症的免疫功能受损。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evidence suggests that complex interactions between the immune system and brain have important etiological and therapeutic implications in schizophrenia. However, the detailed cellular and molecular basis of immune dysfunction in schizophrenia remains poorly characterized. To better understand the immune changes and molecular pathways, we systemically compared the cytokine responses of peripheral blood mononuclear cells (PBMCs) derived from patients with schizophrenia and controls against bacterial, fungal, and purified microbial ligands, and identified aberrant cytokine response patterns to various pathogens, as well as reduced cytokine production after stimulation with muramyl dipeptide (MDP) in schizophrenia. Subsequently, we performed single-cell RNA sequencing on unstimulated and stimulated PBMCs from patients and controls and revealed widespread suppression of antiviral and inflammatory programs as well as impaired chemokine/cytokine-receptor interaction networks in various immune cell subpopulations of schizophrenic patients after MDP stimulation. Moreover, serum MDP levels were elevated in these patients and correlated with the course of the disease, suggesting increased bacterial translocation along with disease progression. In vitro assays revealed that MDP pretreatment altered the functional response of normal PBMCs to its re-stimulation, which partially recapitulated the impaired immune function in schizophrenia. In conclusion, we delineated the molecular and cellular landscape of impaired immune function in schizophrenia, and proposed a mutual interplay between innate immune impairment, reduced pathogen clearance, increased MDP translocation along schizophrenia development, and blunted innate immune response. These findings provide new insights into the pathogenic mechanisms that drive systemic immune activation, neuroinflammation, and brain abnormalities in schizophrenia.
引用
- Gao Y, Fan Y, Yang Z, et al. Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia. Mol Psychiatry. 2021. PMID: 34728799. doi:10.1038/s41380-021-01362-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。